Vaccine for human hepatitis B virus was prepared using
antigen produced by recombinant technology in yeast
(Saccharomyces cerevisiae). Yeast-derived vaccine was safe
and was equally immunogenic and protective against
hepatitis B as plasma-derived vaccine.